Reports for MYLAN PHARMACEUTICALS ULC
Company Name
MYLAN PHARMACEUTICALS ULC
Totals |
||
Shortage reports |
654 |
|
Actual shortage: | 16 (2%) | |
Anticipated shortage: | 6 (1%) | |
Avoided shortage: | 85 (13%) | |
Resolved: | 547 (84%) | |
Discontinuation Reports |
234 |
|
To be discontinued: | 0 (0%) | |
Discontinued: | 234 (100%) | |
Reversed: | 0 (0%) | |
Late reports |
83 (9%) |
|
Overdue reports |
2 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2017-06-16 | 2018-10-10 | 13187 |
CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2019-01-15 | 2020-07-10 | 72306 |
CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-04-12 | 2023-05-01 | 189345 |
CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-10-11 | 2023-11-28 | 206781 |
CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Resolved | 2023-12-21 | 2024-01-10 | 213971 |
CAMPRAL | 333MG | TABLET (DELAYED-RELEASE) | Actual shortage | 2024-05-21 | 2024-06-12 | 228363 |
CLARUS | 10MG | CAPSULE | Resolved | 2017-03-10 | 2017-03-22 | 143 |
CLARUS | 40MG | CAPSULE | Resolved | 2017-03-10 | 2017-03-22 | 148 |
CLARUS | 40MG | CAPSULE | Avoided shortage | 2017-03-31 | 2017-06-28 | 5039 |
CLARUS | 40MG | CAPSULE | Resolved | 2019-03-05 | 2019-05-08 | 77763 |
CLARUS | 10MG | CAPSULE | Resolved | 2019-04-03 | 2019-05-08 | 80416 |
CLARUS | 10MG | CAPSULE | Resolved | 2019-07-09 | 2019-07-17 | 88979 |
CLARUS | 10MG | CAPSULE | Resolved | 2019-07-23 | 2019-10-02 | 89821 |
CLARUS | 10MG | CAPSULE | Resolved | 2019-10-29 | 2020-03-18 | 97440 |
CLARUS | 40MG | CAPSULE | Avoided shortage | 2020-01-24 | 2020-01-28 | 104181 |
CLARUS | 40MG | CAPSULE | Resolved | 2020-03-18 | 2020-04-08 | 108871 |
CLARUS | 10MG | CAPSULE | Resolved | 2021-04-13 | 2021-06-24 | 137415 |
CLARUS | 40MG | CAPSULE | Avoided shortage | 2021-06-30 | 2021-10-13 | 141672 |
CLARUS | 10MG | CAPSULE | Resolved | 2021-06-30 | 2021-12-21 | 141675 |
CLARUS | 40MG | CAPSULE | Resolved | 2022-01-13 | 2022-04-13 | 152648 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
MYLAN-RISPERIDONE | 0.25MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16154 |
MYLAN-RISPERIDONE | 0.50MG | TABLET | Discontinued | 2017-07-18 | 2018-02-15 | 16157 |
MYLAN-RISPERIDONE | 1.0MG | TABLET | Discontinued | 2017-07-18 | 2017-09-08 | 16160 |
MYLAN-RISPERIDONE | 2.0MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16163 |
MYLAN-RISPERIDONE | 3.0MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16166 |
MYLAN-RISPERIDONE | 4.0MG | TABLET | Discontinued | 2017-07-18 | 2017-10-03 | 16169 |
MYLAN-RISPERIDONE ODT | 0.5MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149759 |
MYLAN-RISPERIDONE ODT | 1MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149762 |
MYLAN-RISPERIDONE ODT | 2MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149765 |
MYLAN-RISPERIDONE ODT | 3MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149768 |
MYLAN-RISPERIDONE ODT | 4MG | TABLET (ORALLY DISINTEGRATING) | Discontinued | 2021-11-23 | 2021-11-23 | 149771 |
MYLAN-ROSUVASTATIN | 10MG | TABLET | Discontinued | 2017-11-23 | 2018-04-03 | 30342 |
MYLAN-ROSUVASTATIN | 40MG | TABLET | Discontinued | 2017-11-23 | 2018-05-02 | 30350 |
MYLAN-ROSUVASTATIN | 20MG | TABLET | Discontinued | 2017-11-23 | 2018-07-04 | 30385 |
MYLAN-ROSUVASTATIN | 5MG | TABLET | Discontinued | 2018-04-04 | 2018-07-04 | 44907 |
MYLAN-SELEGILINE | 5MG | TABLET | Discontinued | 2017-07-17 | 2017-07-17 | 16054 |
MYLAN-SERTRALINE | 50MG | CAPSULE | Discontinued | 2017-08-24 | 2018-03-02 | 20295 |
MYLAN-SERTRALINE | 100MG | CAPSULE | Discontinued | 2017-11-23 | 2018-02-15 | 30356 |
MYLAN-SERTRALINE | 25MG | CAPSULE | Discontinued | 2017-11-23 | 2018-02-15 | 30397 |
MYLAN-SIMVASTATIN | 5MG | TABLET | Discontinued | 2019-09-17 | 2019-09-18 | 94112 |